We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
After “allegations of wrongdoing” were connected to Eastman Kodak Company following a $765 million loan from the US government, a review has been announced.
The US International Development Finance Corporation (DFC) has signed a letter of interest (LOI) to offer a $765m loan to support Eastman Kodak’s new arm, Kodak Pharmaceuticals.